(Q86429679)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23510923%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

title

p90(RSK)s mediate the activation of ribosomal RNA synthesis by the hypertrophic agonist phenylephrine in adult cardiomyocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23510923%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23510923%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Ze Zhang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23510923%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Rui Liu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23510923%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Paul A Townsend

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23510923%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

17 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23510923%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular and Cellular Cardiology

26 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23510923%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23510923%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

139-147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23510923%20AND%20SRC:MED&resulttype=core&format=json

Cardiac hypertrophy: a matter of translation.

26 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Ras/Erk signaling is essential for activation of protein synthesis by Gq protein-coupled receptor agonists in adult cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways. MEK-dependent activation of S6K2 in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Regulation of the phosphorylation of elongation factor 2 by MEK-dependent signalling in adult rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Biochemical mechanisms of cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

mTORC1 directly phosphorylates and regulates human MAF1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Regulation of RNA polymerase III transcription during hypertrophic growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Rheb activates protein synthesis and growth in adult rat ventricular cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Regulation and function of the RSK family of protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Activation of mRNA translation in rat cardiac myocytes by insulin involves multiple rapamycin-sensitive steps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

mTOR signaling regulates the processing of pre-rRNA in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Differential expression and regulation of nucleoside transport systems in rat liver parenchymal and hepatoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

ATP-sensitive K(+) channels regulate the concentrative adenosine transporter CNT2 following activation by A(1) adenosine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Biosynthetic labeling of RNA with uracil phosphoribosyltransferase allows cell-specific microarray analysis of mRNA synthesis and decay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Selective isolation of newly synthesized mammalian mRNA after in vivo labeling with 4-thiouridine or 6-thioguanosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

MAD1 and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Cardiac hypertrophy in vivo is associated with increased expression of the ribosomal gene transcription factor UBF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Inhibition of nucleoside transport by protein kinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

The equilibrative nucleoside transporter family, SLC29

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

PD98059 and U0126 activate AMP-activated protein kinase by increasing the cellular AMP:ATP ratio and not via inhibition of the MAP kinase pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Identification of cAMP-dependent kinase as a third in vivo ribosomal protein S6 kinase in pancreatic beta-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

The RSK family of kinases: emerging roles in cellular signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Pharmacological and genetic evaluation of proposed roles of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK), extracellular signal-regulated kinase (ERK), and p90(RSK) in the control of mTORC1 protein signaling by

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

p90 ribosomal S6 kinases play a significant role in early gene regulation in the cardiomyocyte response to G(q)-protein-coupled receptor stimuli, endothelin-1 and α(1)-adrenergic receptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Differential regulation of NHE1 phosphorylation and glucose uptake by inhibitors of the ERK pathway and p90RSK in 3T3-L1 adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

The selectivity of protein kinase inhibitors: a further update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Targeting Na+/H+ exchanger regulation for cardiac protection: a RSKy approach?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2013.03.006

10.1016/J.YJMCC.2013.03.006

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23510923%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference